MUCOSAL MELANOMA

This study is for people with high-risk melanoma who have had surgery to remove their cancer. Researchers are testing if a combination of two immunotherapy drugs works better than the current standard single drug at preventing the cancer from returning. They will use a special bl…

This trial is testing new combinations of immunotherapy drugs given before surgery for patients with advanced melanoma who are predicted to respond poorly to standard treatments. The study involves 494 patients with stage 3 skin melanoma or mucosal melanoma that can be surgically…

This study is testing whether combining the drugs axitinib and nivolumab is a safe and effective first treatment for adults with advanced mucosal melanoma, a rare and aggressive cancer. The researchers believe blocking two different cancer growth pathways at once may work better …

This early-stage trial is testing a new radioactive drug for adults with advanced melanoma that has spread or cannot be removed by surgery. The main goals are to find the safest dose and see if the drug can shrink tumors. Participants receive the drug once every six weeks for up …

This study is for people with a rare and aggressive type of skin cancer called mucosal melanoma who have had it surgically removed. It is testing if adding a drug called sintilimab to standard chemotherapy is better at preventing the cancer from coming back than chemotherapy alon…

This study is testing a new approach for treating stage III melanoma that can be surgically removed. Researchers are injecting two immunotherapy drugs directly into the tumor before surgery, hoping this will be more effective and cause fewer body-wide side effects than standard I…

This trial is for people with mucosal melanoma, a rare and aggressive cancer, that has been surgically removed. It tests whether adding a pill called cabozantinib to an immunotherapy drug (nivolumab) is better at preventing the cancer from returning than the immunotherapy alone. …